pCMV-T7-hAcrVA2.1-NLS(sv40) (BPK5059) Citations (1)

Originally described in: Discovery of widespread Type I and Type V CRISPR-Cas inhibitors.
Marino ND, Zhang JY, Borges AL, Sousa AA, Leon LM, Rauch BJ, Walton RT, Berry JD, Joung JK, Kleinstiver BP, Bondy-Denomy J Science. 2018 Sep 6. pii: science.aau5174. doi: 10.1126/science.aau5174. PubMed Journal

---

Articles Citing pCMV-T7-hAcrVA2.1-NLS(sv40) (BPK5059)

Articles
AcrIIA5 Suppresses Base Editors and Reduces Their Off-Target Effects. Liang M, Sui T, Liu Z, Chen M, Liu H, Shan H, Lai L, Li Z. Cells. 2020 Jul 27;9(8). pii: cells9081786. doi: 10.3390/cells9081786. PubMed

If you have published an article using this material, please email us at to have your article added to this page.